APA (7th ed.) Citation

Chitoran, E., Rotaru, V., Stefan, D., Gullo, G., & Simion, L. (2025). Blocking Tumoral Angiogenesis VEGF/VEGFR Pathway: Bevacizumab—20 Years of Therapeutic Success and Controversy. Cancers, 17(7), 1126. https://doi.org/10.3390/cancers17071126

Chicago Style (17th ed.) Citation

Chitoran, Elena, Vlad Rotaru, Daniela-Cristina Stefan, Giuseppe Gullo, and Laurentiu Simion. "Blocking Tumoral Angiogenesis VEGF/VEGFR Pathway: Bevacizumab—20 Years of Therapeutic Success and Controversy." Cancers 17, no. 7 (2025): 1126. https://doi.org/10.3390/cancers17071126.

MLA (9th ed.) Citation

Chitoran, Elena, et al. "Blocking Tumoral Angiogenesis VEGF/VEGFR Pathway: Bevacizumab—20 Years of Therapeutic Success and Controversy." Cancers, vol. 17, no. 7, 2025, p. 1126, https://doi.org/10.3390/cancers17071126.